- Presentations
- 4
- Markets
- 1
Aristada is a brand of Aripiprazole lauroxil marketed by Alkermes, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Aripiprazole lauroxil
- Brand owner
- Alkermes
- Registered in
- United States
- Strengths and forms
- 1064 mg/3.9 mL extended-release injectable suspension, 441 mg/1.6 mL extended-release injectable suspension, 662 mg/2.4 mL extended-release injectable suspension, 882 mg/3.2 mL extended-release injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Aristada 1064 mg/3.9 mL extended-release injectable suspensionIntramuscular | Alkermes | US FDA | Available on request |
| Aristada 441 mg/1.6 mL extended-release injectable suspensionIntramuscular | Alkermes | US FDA | Available on request |
| Aristada 662 mg/2.4 mL extended-release injectable suspensionIntramuscular | Alkermes | US FDA | Available on request |
| Aristada 882 mg/3.2 mL extended-release injectable suspensionIntramuscular | Alkermes | US FDA | Available on request |
Equivalent brands
Other brands of Aripiprazole lauroxil.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Aristada
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.